Search

Author/Creator Baba, E

1. 606TiPRandomized phase II study of FOLFIRI plus ramucirumab (Rmab) versus FOLFOXIRI plus Rmab as first-line treatment for patients with metastatic colorectal cancer (mCRC): WJOG9216G. (23rd October 2018)

Authors:
Kito, Y; Yamada, T; Matsumoto, T; Yasui, H; Murata, K; Makiyama, A; Hara, H; Baba, E; Nishio, K; Yoshimura, K; Hironaka, S; Muro, K; Yamazaki, K
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. (22nd November 2018)

Authors:
Muro, K; Van Cutsem, E; Narita, Y; Pentheroudakis, G; Baba, E; Li, J; Ryu, M -H; Zamaniah, W I Wan; Yong, W -P; Yeh, K -H; Kato, K; Lu, Z; Cho, B C; Nor, I M; Ng, M; Chen, L -T; Nakajima, T E; Shitara, K; Kawakami, H; Tsushima, T
Journal:
Annals of oncology
Issue:
Volume 30:Number 1(2019)
Page Start:
19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. (22nd November 2018)

Authors:
Muro, K; Lordick, F; Tsushima, T; Pentheroudakis, G; Baba, E; Lu, Z; Cho, B C; Nor, I M; Ng, M; Chen, L -T; Kato, K; Li, J; Ryu, M -H; Zamaniah, W I Wan; Yong, W -P; Yeh, K -H; Nakajima, T E; Shitara, K; Kawakami, H; Narita, Y
Journal:
Annals of oncology
Issue:
Volume 30:Number 1(2019)
Page Start:
34
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗